Latham & Watkins·HEALTHCARE

Nine drugmakers join Generous MFN pricing model in Medicaid

White House announced nine pharmaceutical manufacturers voluntarily participating in the Generous payment model implementing MFN pricing in Medicaid, receiving Section 232 tariff relief and waivers from Medicare MFN requirements.

drug-pricing-mfnmedicaid-generous-modelinflation-reduction-act340b-program-cmspharmaceutical-tariffs
Read the original firm alert → Friday, September 11, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.